Area of research
Oncology · Hematology
Research interest
Research interests include CAR-T cell therapy research, Chronic Myeloid Leukemia Treatments, Photonic and Optical Devices, and Chronic Lymphocytic Leukemia Research.
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>
Dual targeting of CD19 and CD22 with Bicistronic CAR-T cells in Patients with Relapsed/Refractory Large B Cell Lymphoma
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Real-World Data of High-Grade Lymphoma Patients Treated with CD19 CAR-T in England
Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia
The risk of acute liver injury associated with the use of antibiotics—evaluating robustness of results in the pharmacoepidemiological research on outcomes of therapeutics by a European consortium (PROTECT) project.
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile